EPA is More Effective than DHA to Improve Depression-Like Behavior, Glia Cell Dysfunction and Hippcampal Apoptosis Signaling in a Chronic Stress-Induced Rat Model of Depression

International Journal of Molecular Sciences
Zhilan PengCai Song

Abstract

Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment. However, possible mechanisms remain unclear. Here, a chronic unpredictable mild stress (CUMS)-induced model of depression was used to compare EPA and DHA anti-depressant effects. After EPA or DHA feeding, depression-like behavior, brain n-3/n-6 PUFAs profile, serum corticosterone and cholesterol concentration, hippocampal neurotransmitters, microglial and astrocyte related function, as well as neuronal apoptosis and survival signaling pathways were studied. EPA was more effective than DHA to ameliorate CUMS-induced body weight loss, and depression-like behaviors, such as increasing sucrose preference, shortening immobility time and increasing locomotor activity. CUMS-induced corticosterone elevation was reversed by bother fatty acids, while increased cholesterol was only reduced by EPA supplement. Lower hippocampal noradrenaline and 5-hydroxytryptamine concentrations in CUMS rats were also reversed by both EPA and DHA supplement. However, even though CUMS-induced microglial activation and associated increased IL-1β were inhibited by both EPA and DHA supplement, increased IL-6 and TNF-α levels ...Continue Reading

References

Jan 3, 2001·The Journal of Clinical Investigation·P P Tak, G S Firestein
Jun 27, 2002·Journal of the American Chemical Society·Yin WangMichael F Brown
Jun 3, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Henry K TengBarbara L Hempstead
Nov 10, 2007·Psychosomatic Medicine·Sarah M ConklinMatthew F Muldoon
Jan 24, 2009·Apoptosis : an International Journal on Programmed Cell Death·Oren A LevyLloyd A Greene
Aug 28, 2009·The Journal of Clinical Psychiatry·David MischoulonMaurizio Fava
Mar 12, 2010·Neuroscience Letters·Hisatsugu KoshimizuMasami Kojima
Jul 6, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Michael Maes
Jul 6, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Cai Song, Hua Wang
Sep 8, 2010·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·V Wee Yong
Oct 15, 2010·Journal of Neuroimmunology·Anna Członkowska, Iwona Kurkowska-Jastrzębska
May 28, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Marjan AjamiHamidreza Pazoki-Toroudi
Jun 22, 2012·Psychoneuroendocrinology·Arianne K B van Reedt DortlandFrans G Zitman
Jul 20, 2016·Neuroscience Bulletin·Philippe Leff-GelmanDavid Ellioth Pulido-Ascencio
Oct 13, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sally A AbuelezzYosra Magdy
Oct 26, 2018·Cognitive, Affective & Behavioral Neuroscience·M R EhlersR M Todd
Mar 31, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jan KorbeckiMieczysław Dutka

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Super Maze Behavior Analysis System
SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.